Search Within

Nancy T Sklarin

  1. "American Society of Clinical Oncology"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (8)
Groups
  1. Breast Medicine Service (20)
  2. Department of Medicine (20)
  3. Solid Tumor Oncology Division (20)
  4. Survivorship Research (15)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)
  6. Epidemiology and Biostatistics (10)

More Groups

People
  1. Clifford Hudis (15)
  2. Larry Norton (10)
  3. Andrew Seidman (9)
  4. Monica Fornier (8)
  5. Gabriella D'Andrea-Carlino (7)
  6. Mary Ellen Moynahan (6)

More People

Years
  1. 2015 (2)
  2. 2012 (2)
  3. 2011 (3)
  4. 2010 (2)
  5. 2008 (1)
  6. 2007 (2)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Journal of Oncology Practice (1)
Publishers
  1. American Society of Clinical Oncology (20)

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Chandarlapaty, S.; Dickler, M. N.; Ulaner, G.; Zamora, S. J.; Sterlin, V.; Iasonos, A.; Coughlin, C. M.; Morozov, A.; Ero, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Incidence of hypersensitivity reactions (HSRs) to albumin-bound paclitaxel (ABI) in patients (pts) with a history of HSR to cremophor-based paclitaxel (P)
    Meeting Abstract

    Timoney, J. P.; McGuffy, D.; DeRitis, D.; Tyler, E.; Sumka, J.; Pozotrigo, M.; Bhatt, V.; Chan, A.; Sklarin, N. T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Electronic chemotherapy order entry: A major cancer center's implementation
    Journal Article

    Sklarin, N. T.; Granovsky, S.; O'Reilly, E. M.; Zelenetz, A. D.
    Journal of Oncology Practice (2011)

    Fulltext@MSK | Save
  • Pathologic features and outcomes of pregnancy-associated breast cancer (PABC): A case control study
    Meeting Abstract

    Murphy, C.; Mallam, D.; Stein, S.; Patil, S.; Howard, J.; Sklarin, N. T.; Gemignani, M.; Hudis, C.; Seidman, A. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Chang, J. C.; Abbruzzi, A.; Patil, S.; Modi, S.; Seidman, A. D.; Sklarin, N. T.; Norton, L.; Hudis, C.; Fornier, M. N.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save